SYMBOL;TYPE;SOURCE;ENSEMBL;ENTREZID;GENENAME
CDH1;Melanocytes;;ENSG00000039068;999;cadherin 1
ERBB3;Melanocytes;;ENSG00000065361;2065;erb-b2 receptor tyrosine kinase 3
TYR;Melanocytes;Zabierowski et. Al (2011);ENSG00000077498;7299;tyrosinase
DCT;Melanocytes;Zabierowski et. Al (2011);ENSG00000080166;1638;dopachrome tautomerase
SOX10;Melanocytes;;ENSG00000100146;6663;SRY-box transcription factor 10
TYRP1;Melanocytes;;ENSG00000107165;7306;tyrosinase related protein 1
MLANA;Melanocytes;Zabierowski et. Al (2011);ENSG00000120215;2315;melan-A
PAX3;Melanocytes;;ENSG00000135903;5077;paired box 3
EDNRB;Melanocytes;;ENSG00000136160;1910;endothelin receptor type B
KIT;Melanocytes;Zabierowski et. Al (2011);ENSG00000157404;3815;KIT proto-oncogene, receptor tyrosine kinase
PMEL;Melanocytes;Zabierowski et. Al (2011);ENSG00000185664;6490;premelanosome protein
MITF;Melanocytes;Zabierowski et. Al (2011);ENSG00000187098;4286;melanocyte inducing transcription factor
FOXC1;DSCs;;ENSG00000054598;2296;forkhead box C1
NGFR;DSCs;Zabierowski et. Al (2011);ENSG00000064300;4804;nerve growth factor receptor
JAG1;DSCs;;ENSG00000101384;182;jagged canonical Notch ligand 1
SNAI1;DSCs;;ENSG00000124216;6615;snail family transcriptional repressor 1
NES;DSCs;Zabierowski et. Al (2011);ENSG00000132688;10763;nestin
PAX3;DSCs;;ENSG00000135903;5077;paired box 3
FRZB;DSCs;;ENSG00000162998;2487;frizzled related protein
MSX1;DSCs;;ENSG00000163132;4487;msh homeobox 1
CDH2;DSCs;;ENSG00000170558;1000;cadherin 2
SOX2;DSCs;;ENSG00000181449;6657;SRY-box transcription factor 2
HES4;DSCs;;ENSG00000188290;57801;hes family bHLH transcription factor 4
S100A4;DSCs;;ENSG00000196154;6275;S100 calcium binding protein A4
VIM;Fibroblasts;;ENSG00000026025;7431;vimentin
ELN;Fibroblasts;;ENSG00000049540;2006;elastin
FAP;Fibroblasts;;ENSG00000078098;2191;fibroblast activation protein alpha
FN1;Fibroblasts;;ENSG00000115414;2335;fibronectin 1
LAMA5;Fibroblasts;;ENSG00000130702;3911;laminin subunit alpha 5
PDGFRA;Fibroblasts;;ENSG00000134853;5156;platelet derived growth factor receptor alpha
SERPINH1;Fibroblasts;;ENSG00000149257;871;serpin family H member 1
ITGB1;Fibroblasts;;ENSG00000150093;3688;integrin subunit beta 1
THY1;Fibroblasts;;ENSG00000154096;7070;Thy-1 cell surface antigen
DLK1;Fibroblasts;;ENSG00000185559;8788;delta like non-canonical Notch ligand 1
LAMA2;Fibroblasts;;ENSG00000196569;3908;laminin subunit alpha 2
DPP4;Fibroblasts;;ENSG00000197635;1803;dipeptidyl peptidase 4
GAB2;Melanoma_up;Cherepakhin et. al (2022);ENSG00000033327;9846;GRB2 associated binding protein 2
MAP3K1;Melanoma_up;Cherepakhin et. al (2022);ENSG00000095015;4214;mitogen-activated protein kinase kinase kinase 1
MET;Melanoma_up;Cherepakhin et. al (2022);ENSG00000105976;4233;MET proto-oncogene, receptor tyrosine kinase
CCND1;Melanoma_up;Cherepakhin et. al (2022);ENSG00000110092;595;cyclin D1
PIK3CA;Melanoma_up;Cherepakhin et. al (2022);ENSG00000121879;5290;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
APC;Melanoma_down;Cherepakhin et. al (2022);ENSG00000134982;324;APC regulator of WNT signaling pathway
RAC1;Melanoma_up;Cherepakhin et. al (2022);ENSG00000136238;5879;Rac family small GTPase 1
TP53;Melanoma_down;Cherepakhin et. al (2022);ENSG00000141510;7157;tumor protein p53
ERBB2;Melanoma_up;Cherepakhin et. al (2022);ENSG00000141736;2064;erb-b2 receptor tyrosine kinase 2
EGFR;Melanoma_up;Cherepakhin et. al (2022);ENSG00000146648;1956;epidermal growth factor receptor
CDKN2A;Melanoma_down;Cherepakhin et. al (2022);ENSG00000147889;1029;cyclin dependent kinase inhibitor 2A
KIT;Melanoma_up;Cherepakhin et. al (2022);ENSG00000157404;3815;KIT proto-oncogene, receptor tyrosine kinase
BRAF;Melanoma_up;Cherepakhin et. al (2022);ENSG00000157764;673;B-Raf proto-oncogene, serine/threonine kinase
BAP1;Melanoma_down;Cherepakhin et. al (2022);ENSG00000163930;8314;BRCA1 associated protein 1
CTNNB1;Melanoma_up;Cherepakhin et. al (2022);ENSG00000168036;1499;catenin beta 1
MAP2K1;Melanoma_up;Cherepakhin et. al (2022);ENSG00000169032;5604;mitogen-activated protein kinase kinase 1
PTEN;Melanoma_down;Cherepakhin et. al (2022);ENSG00000171862;5728;phosphatase and tensin homolog
HRAS;Melanoma_up;Cherepakhin et. al (2022);ENSG00000174775;3265;HRas proto-oncogene, GTPase
PTPN11;Melanoma_up;Cherepakhin et. al (2022);ENSG00000179295;5781;protein tyrosine phosphatase non-receptor type 11
NF1;Melanoma_down;Cherepakhin et. al (2022);ENSG00000196712;4763;neurofibromin 1
NRAS;Melanoma_up;Cherepakhin et. al (2022);ENSG00000213281;4893;NRAS proto-oncogene, GTPase
KRAS;Melanoma_up;Cherepakhin et. al (2022);;;
PSPH;Melanoma_up;Xie et. al (2022);;5723;
SPP1;Melanoma_up;Xie et. al (2022);;6696;
IGF2BP3;Melanoma_up;Xie et. al (2022);;10643;
DNAJB9;Melanoma_up;Xie et. al (2022);;4189;
MAGEA6;Melanoma_up;Xie et. al (2022);;4105;
MAGEA3;Melanoma_up;Xie et. al (2022);;4102;
ADAM12;Melanoma_up;Xie et. al (2022);;8038;
RRM2;Melanoma_up;Xie et. al (2022);;6241;
ITGB3;Melanoma_up;Xie et. al (2022);;3690;
DHFR;Melanoma_up;Xie et. al (2022);;1719;
PAEP;Melanoma_up;Xie et. al (2022);;5047;
CDK1;Melanoma_up;Xie et. al (2022);;983;
UGT8;Melanoma_up;Xie et. al (2022);;7368;
EXOC5;Melanoma_up;Xie et. al (2022);;10640;
CENPN;Melanoma_up;Xie et. al (2022);;55839;
MYBL1;Melanoma_up;Xie et. al (2022);;4603;
CITED1;Melanoma_up;Xie et. al (2022);;4435;
SKAP2;Melanoma_up;Xie et. al (2022);;8935;
RARRES1;Melanoma_up;Xie et. al (2022);;5918;
ITGA4;Melanoma_up;Xie et. al (2022);;3676;
SCD;Melanoma_up;Xie et. al (2022);;6319;
NFYA;Melanoma_up;Xie et. al (2022);;4800;
FOLH1B;Melanoma_up;Xie et. al (2022);;219595;
FOLH1;Melanoma_up;Xie et. al (2022);;2346;
MAD2L1;Melanoma_up;Xie et. al (2022);;4085;
PLOD2;Melanoma_up;Xie et. al (2022);;5352;
MCM10;Melanoma_up;Xie et. al (2022);;55388;
SKAP2;Melanoma_up;Xie et. al (2022);;8935;
PIP5K1A;Melanoma_up;Xie et. al (2022);;8394;
BUB1;Melanoma_up;Xie et. al (2022);;699;
MRE11A;Melanoma_up;Xie et. al (2022);;4361;
SFRP4;Melanoma_up;Xie et. al (2022);;6424;
YIPF4;Melanoma_up;Xie et. al (2022);;84272;
DNAJC10;Melanoma_up;Xie et. al (2022);;54431;
CDCA8;Melanoma_up;Xie et. al (2022);;55143;
NEK2;Melanoma_up;Xie et. al (2022);;4751;
BRIP1;Melanoma_up;Xie et. al (2022);;83990;
CD46;Melanoma_up;Xie et. al (2022);;4179;
LIMK1;Melanoma_up;Xie et. al (2022);;3984;
PYGB;Melanoma_up;Xie et. al (2022);;5834;
CENPM;Melanoma_up;Xie et. al (2022);;79019;
ACSL3;Melanoma_up;Xie et. al (2022);;2181;
PSPH;Melanoma_up;Xie et. al (2022);;5723;
SLC33A1;Melanoma_up;Xie et. al (2022);;9197;
EMC1;Melanoma_up;Xie et. al (2022);;23065;
ASPM;Melanoma_up;Xie et. al (2022);;259266;
GLUD2;Melanoma_up;Xie et. al (2022);;2747;
HIPK3;Melanoma_up;Xie et. al (2022);;10114;
GAGE1;Melanoma_up;Xie et. al (2022);;6;
GAGE12;Melanoma_up;Xie et. al (2022);;;
NCAPG;Melanoma_up;Xie et. al (2022);;64151;
LBR;Melanoma_up;Xie et. al (2022);;3930;
C1orf112;Melanoma_up;Xie et. al (2022);;55732;
SEC23A;Melanoma_up;Xie et. al (2022);;10484;
TWF1;Melanoma_up;Xie et. al (2022);;5756;
HSPA13;Melanoma_up;Xie et. al (2022);;6782;
CDK1;Melanoma_up;Xie et. al (2022);;983;
MPHOSPH9;Melanoma_up;Xie et. al (2022);;10198;
SEC23IP;Melanoma_up;Xie et. al (2022);;11196;
TGM2;Melanoma_up;Xie et. al (2022);;7052;
S100A7;Melanoma_down;Xie et. al (2022);;6278;
KRT14;Melanoma_down;Xie et. al (2022);;3861;
KRT16;Melanoma_down;Xie et. al (2022);;3868;
SPRR1A;Melanoma_down;Xie et. al (2022);;6698;
KRT6A;Melanoma_down;Xie et. al (2022);;3853;
KRT17;Melanoma_down;Xie et. al (2022);;3872;
JUP;Melanoma_down;Xie et. al (2022);;3728;
KRT5;Melanoma_down;Xie et. al (2022);;3852;
KRT6C;Melanoma_down;Xie et. al (2022);;2868873;
KRT6B;Melanoma_down;Xie et. al (2022);;3854;
LOR;Melanoma_down;Xie et. al (2022);;4014;
SFN;Melanoma_down;Xie et. al (2022);;2810;
LGALS7B;Melanoma_down;Xie et. al (2022);;653499;
LGALS7;Melanoma_down;Xie et. al (2022);;3963;
PKP1;Melanoma_down;Xie et. al (2022);;5317;
S100A8;Melanoma_down;Xie et. al (2022);;6279;
FLG;Melanoma_down;Xie et. al (2022);;2312;
KRT1;Melanoma_down;Xie et. al (2022);;3848;
SERPINB3;Melanoma_down;Xie et. al (2022);;6317;
CALML5;Melanoma_down;Xie et. al (2022);;51806;
KRT15;Melanoma_down;Xie et. al (2022);;3866;
SPRR1B;Melanoma_down;Xie et. al (2022);;6699;
KRT6B;Melanoma_down;Xie et. al (2022);;3854;
PI3;Melanoma_down;Xie et. al (2022);;5266;
LY6D;Melanoma_down;Xie et. al (2022);;8581;
KRT17;Melanoma_down;Xie et. al (2022);;3872;
SERPINB5;Melanoma_down;Xie et. al (2022);;5268;
S100A8;Melanoma_down;Xie et. al (2022);;6279;
TRIM29;Melanoma_down;Xie et. al (2022);;23650;
DSG1;Melanoma_down;Xie et. al (2022);;1828;
S100A2;Melanoma_down;Xie et. al (2022);;6273;
TRIM29;Melanoma_down;Xie et. al (2022);;23650;
LYPD3;Melanoma_down;Xie et. al (2022);;27076;
SPRR2B;Melanoma_down;Xie et. al (2022);;6701;
TACSTD2;Melanoma_down;Xie et. al (2022);;4070;
SPINK5;Melanoma_down;Xie et. al (2022);;11005;
SFN;Melanoma_down;Xie et. al (2022);;2810;
CLCA2;Melanoma_down;Xie et. al (2022);;9635;
CDSN;Melanoma_down;Xie et. al (2022);;1041;
PPL;Melanoma_down;Xie et. al (2022);;5493;
S100A9;Melanoma_down;Xie et. al (2022);;6280;
SPRR1A;Melanoma_down;Xie et. al (2022);;6698;
ALOX12B;Melanoma_down;Xie et. al (2022);;242;
AQP3;Melanoma_down;Xie et. al (2022);;360;
CALML3;Melanoma_down;Xie et. al (2022);;810;
CDSN;Melanoma_down;Xie et. al (2022);;1041;
DSP;Melanoma_down;Xie et. al (2022);;1832;
DSC1;Melanoma_down;Xie et. al (2022);;1823;
FGFR3;Melanoma_down;Xie et. al (2022);;2261;
CST6;Melanoma_down;Xie et. al (2022);;1474;
SERPINB4;Melanoma_down;Xie et. al (2022);;6318;
CLCA2;Melanoma_down;Xie et. al (2022);;9635;
RAB25;Melanoma_down;Xie et. al (2022);;57111;
SFN;Melanoma_down;Xie et. al (2022);;2810;
COL17A1;Melanoma_down;Xie et. al (2022);;1308;
KLK10;Melanoma_down;Xie et. al (2022);;5655;
CWH43;Melanoma_down;Xie et. al (2022);;80157;
CSTA;Melanoma_down;Xie et. al (2022);;1475;
ZNF750;Melanoma_down;Xie et. al (2022);;79755;
AHNAK;Melanoma_down;Xie et. al (2022);;79026;
JUP;Melanoma_down;Xie et. al (2022);;3728;
DUOX1;Melanoma_down;Xie et. al (2022);;53905;
TYRP1;Melanoma_down;Xie et. al (2022);;7306;
TPSAB1;Melanoma_down;Xie et. al (2022);;7177;
EVPL;Melanoma_down;Xie et. al (2022);;2125;
CRCT1;Melanoma_down;Xie et. al (2022);;54544;
EPHX3;Melanoma_down;Xie et. al (2022);;79852;
LCE2B;Melanoma_down;Xie et. al (2022);;26239;
DSC2;Melanoma_down;Xie et. al (2022);;1824;
PI3;Melanoma_down;Xie et. al (2022);;5266;
KLK11;Melanoma_down;Xie et. al (2022);;11012;
CLIC3;Melanoma_down;Xie et. al (2022);;9022;
CDA;Melanoma_down;Xie et. al (2022);;978;
CXCL14;Melanoma_down;Xie et. al (2022);;9547;
SERPINB3;Melanoma_down;Xie et. al (2022);;6317;
PCSK2;Melanoma_down;Xie et. al (2022);;5126;
DSC3;Melanoma_down;Xie et. al (2022);;1825;
SCNN1A;Melanoma_down;Xie et. al (2022);;6337;
SOX15;Melanoma_down;Xie et. al (2022);;6665;
BBOX1;Melanoma_down;Xie et. al (2022);;8424;
CLCA2;Melanoma_down;Xie et. al (2022);;9635;
CD24;Melanoma_down;Xie et. al (2022);;;
CA12;Melanoma_down;Xie et. al (2022);;771;
DIO2;Melanoma_down;Xie et. al (2022);;1734;
RAPGEFL1;Melanoma_down;Xie et. al (2022);;51195;
NMU;Melanoma_down;Xie et. al (2022);;10874;
TGM1;Melanoma_down;Xie et. al (2022);;7051;
CDH3;Melanoma_down;Xie et. al (2022);;1001;
CD24;Melanoma_down;Xie et. al (2022);;100133941;
TFAP2B;Melanoma_down;Xie et. al (2022);;7021;
POU2F3;Melanoma_down;Xie et. al (2022);;25833;
KRT10;Melanoma_down;Xie et. al (2022);;3858;
C1orf116;Melanoma_down;Xie et. al (2022);;79098;
SERPINB4;Melanoma_down;Xie et. al (2022);;6318;
INB3;Melanoma_down;Xie et. al (2022);;;
RHCG;Melanoma_down;Xie et. al (2022);;51458;
LAMA3;Melanoma_down;Xie et. al (2022);;3909;
IVL;Melanoma_down;Xie et. al (2022);;3713;
PERP;Melanoma_down;Xie et. al (2022);;64065;
KRT10;Melanoma_down;Xie et. al (2022);;3858;
EPN3;Melanoma_down;Xie et. al (2022);;55040;
IRX4;Melanoma_down;Xie et. al (2022);;50805;
AQP3;Melanoma_down;Xie et. al (2022);;360;
CLCA2;Melanoma_down;Xie et. al (2022);;9635;
TPSB2;Melanoma_down;Xie et. al (2022);;64499;
DSC3;Melanoma_down;Xie et. al (2022);;1825;
RHOD;Melanoma_down;Xie et. al (2022);;29984;
GJB3;Melanoma_down;Xie et. al (2022);;2707;
EGFR;Melanoma_down;Xie et. al (2022);;1956;
KRT2;Melanoma_down;Xie et. al (2022);;3849;
FGFR2;Melanoma_down;Xie et. al (2022);;2263;
TPPP3;Melanoma_down;Xie et. al (2022);;51673;
DSG3;Melanoma_down;Xie et. al (2022);;1830;
S100A14;Melanoma_down;Xie et. al (2022);;57402;
LAD1;Melanoma_down;Xie et. al (2022);;3898;
COL7A1;Melanoma_down;Xie et. al (2022);;1294;
POF1B;Melanoma_down;Xie et. al (2022);;79983;
ALOXE3;Melanoma_down;Xie et. al (2022);;59344;
IL1R2;Melanoma_down;Xie et. al (2022);;7850;
ARG1;Melanoma_down;Xie et. al (2022);;383;
CRABP2;Melanoma_down;Xie et. al (2022);;1382;
KRT10;Melanoma_down;Xie et. al (2022);;3858;
CD24;Melanoma_down;Xie et. al (2022);;;
SCEL;Melanoma_down;Xie et. al (2022);;8796;
SPINT1;Melanoma_down;Xie et. al (2022);;6692;
S100P;Melanoma_down;Xie et. al (2022);;6286;
EFNA3;Melanoma_down;Xie et. al (2022);;1944;
SDC1;Melanoma_down;Xie et. al (2022);;6382;
PTGDS;Melanoma_down;Xie et. al (2022);;5730;
ITGB4;Melanoma_down;Xie et. al (2022);;3691;
KLK7;Melanoma_down;Xie et. al (2022);;5650;
LY6G6C;Melanoma_down;Xie et. al (2022);;80740;
CD1C;Melanoma_down;Xie et. al (2022);;911;
DST;Melanoma_down;Xie et. al (2022);;667;
FGFBP1;Melanoma_down;Xie et. al (2022);;9982;
ANK3;Melanoma_down;Xie et. al (2022);;288;
SERPINB7;Melanoma_down;Xie et. al (2022);;8710;
KLF5;Melanoma_down;Xie et. al (2022);;688;
STMN2;Melanoma_down;Xie et. al (2022);;11075;
ALDH3B2;Melanoma_down;Xie et. al (2022);;222;
GPR87;Melanoma_down;Xie et. al (2022);;53836;
CD24;Melanoma_down;Xie et. al (2022);;;
PTK6;Melanoma_down;Xie et. al (2022);;5753;
TNXB;Melanoma_down;Xie et. al (2022);;;
FAM107A;Melanoma_down;Xie et. al (2022);;11170;
KRT75;Melanoma_down;Xie et. al (2022);;9119;
LGALSL;Melanoma_down;Xie et. al (2022);;29094;
COMP;Melanoma_down;Xie et. al (2022);;1311;
TNXA;Melanoma_down;Xie et. al (2022);;;
MAP7;Melanoma_down;Xie et. al (2022);;9053;
TPSAB1;Melanoma_down;Xie et. al (2022);;7177;
PTGDS;Melanoma_down;Xie et. al (2022);;5730;
CDH1;Melanoma_down;Xie et. al (2022);;999;
DEFB1;Melanoma_down;Xie et. al (2022);;1672;
WNT4;Melanoma_down;Xie et. al (2022);;54361;
KRT23;Melanoma_down;Xie et. al (2022);;25984;
MT1M;Melanoma_down;Xie et. al (2022);;4499;
TPSAB1;Melanoma_down;Xie et. al (2022);;7177;
PDZK1IP1;Melanoma_down;Xie et. al (2022);;10158;
AZGP1;Melanoma_down;Xie et. al (2022);;563;
TPSB2;Melanoma_down;Xie et. al (2022);;64499;
KRT7;Melanoma_down;Xie et. al (2022);;3855;
HAL;Melanoma_down;Xie et. al (2022);;3034;
SERPINB13;Melanoma_down;Xie et. al (2022);;5275;
SLPI;Melanoma_down;Xie et. al (2022);;6590;
TP63;Melanoma_down;Xie et. al (2022);;8626;
KLK5;Melanoma_down;Xie et. al (2022);;25818;
AKR1B10;Melanoma_down;Xie et. al (2022);;57016;
ALDH3A1;Melanoma_down;Xie et. al (2022);;218;
KCNK7;Melanoma_down;Xie et. al (2022);;10089;
GJB5;Melanoma_down;Xie et. al (2022);;2709;
KLK8;Melanoma_down;Xie et. al (2022);;11202;
CDHR1;Melanoma_down;Xie et. al (2022);;92211;
CCL27;Melanoma_down;Xie et. al (2022);;10850;
FCGBP;Melanoma_down;Xie et. al (2022);;8857;
PTGDS;Melanoma_down;Xie et. al (2022);;5730;
IL1R2;Melanoma_down;Xie et. al (2022);;7850;
EPS8L1;Melanoma_down;Xie et. al (2022);;54869;
FERMT1;Melanoma_down;Xie et. al (2022);;55612;
PKP3;Melanoma_down;Xie et. al (2022);;11187;
CLTB;Melanoma_down;Xie et. al (2022);;1212;
PSORS1C2;Melanoma_down;Xie et. al (2022);;170680;
EREG;Melanoma_down;Xie et. al (2022);;2069;
SLURP1;Melanoma_down;Xie et. al (2022);;57152;
TMEM45A;Melanoma_down;Xie et. al (2022);;55076;
HR;Melanoma_down;Xie et. al (2022);;55806;
POU3F1;Melanoma_down;Xie et. al (2022);;5453;
HOPX;Melanoma_down;Xie et. al (2022);;84525;
CRIP1;Melanoma_down;Xie et. al (2022);;1396;
ADIRF;Melanoma_down;Xie et. al (2022);;10974;
LCN2;Melanoma_down;Xie et. al (2022);;3934;
FCER1A;Melanoma_down;Xie et. al (2022);;2205;
TPSAB1;Melanoma_down;Xie et. al (2022);;;
SPINT2;Melanoma_down;Xie et. al (2022);;10653;
CD24;Melanoma_down;Xie et. al (2022);;;
LSR;Melanoma_down;Xie et. al (2022);;51599;
ADCY2;Melanoma_down;Xie et. al (2022);;108;
CHP2;Melanoma_down;Xie et. al (2022);;63928;
TUBA4A;Melanoma_down;Xie et. al (2022);;7277;
ELMO3;Melanoma_down;Xie et. al (2022);;79767;
CWH43;Melanoma_down;Xie et. al (2022);;80157;
AHNAK2;Melanoma_down;Xie et. al (2022);;113146;
CRLF1;Melanoma_down;Xie et. al (2022);;9244;
MYO6;Melanoma_down;Xie et. al (2022);;4646;
CA12;Melanoma_down;Xie et. al (2022);;771;
NDUFA4L2;Melanoma_down;Xie et. al (2022);;56901;
HLA-DQB2;Melanoma_down;Xie et. al (2022);;3120;
KLF4;Melanoma_down;Xie et. al (2022);;9314;
F2RL1;Melanoma_down;Xie et. al (2022);;2150;
LAD1;Melanoma_down;Xie et. al (2022);;3898;
HPGD;Melanoma_down;Xie et. al (2022);;3248;
VSNL1;Melanoma_down;Xie et. al (2022);;7447;
IL36RN;Melanoma_down;Xie et. al (2022);;26525;
CKMT1A;Melanoma_down;Xie et. al (2022);;;
MMP1;Melanoma_down;Xie et. al (2022);;4312;
SLC15A1;Melanoma_down;Xie et. al (2022);;6564;
TP53AIP1;Melanoma_down;Xie et. al (2022);;63970;
CYP26B1;Melanoma_down;Xie et. al (2022);;56603;
SOSTDC1;Melanoma_down;Xie et. al (2022);;25928;
CA12;Melanoma_down;Xie et. al (2022);;771;
MFAP4;Melanoma_down;Xie et. al (2022);;4239;
EPHA4;Melanoma_down;Xie et. al (2022);;2043;
DCT;Melanoma_down;Xie et. al (2022);;1638;
GNAL;Melanoma_down;Xie et. al (2022);;2774;
DCT;Melanoma_down;Xie et. al (2022);;1638;
CFD;Melanoma_down;Xie et. al (2022);;1675;
PRSS3P2;Melanoma_down;Xie et. al (2022);;154754;
CDKN1C;Melanoma_down;Xie et. al (2022);;1028;
MALL;Melanoma_down;Xie et. al (2022);;7851;
ST14;Melanoma_down;Xie et. al (2022);;6768;
ITGB4;Melanoma_down;Xie et. al (2022);;3691;
DCT;Melanoma_down;Xie et. al (2022);;1638;
EMX2;Melanoma_down;Xie et. al (2022);;2018;
EHF;Melanoma_down;Xie et. al (2022);;26298;
PRSS3;Melanoma_down;Xie et. al (2022);;5646;
CCL19;Melanoma_down;Xie et. al (2022);;6363;
DST;Melanoma_down;Xie et. al (2022);;667;
KCND3;Melanoma_down;Xie et. al (2022);;3752;
GJA1;Melanoma_down;Xie et. al (2022);;2697;
KLF5;Melanoma_down;Xie et. al (2022);;688;
PLPPR4;Melanoma_down;Xie et. al (2022);;9890;
CDS1;Melanoma_down;Xie et. al (2022);;1040;
AIM1L;Melanoma_down;Xie et. al (2022);;55057;
PTN;Melanoma_down;Xie et. al (2022);;5764;
FXYD3;Melanoma_down;Xie et. al (2022);;5349;
PRSS8;Melanoma_down;Xie et. al (2022);;5652;
GATA3;Melanoma_down;Xie et. al (2022);;2625;
KLF4;Melanoma_down;Xie et. al (2022);;9314;
AQP3;Melanoma_down;Xie et. al (2022);;360;
MYH11;Melanoma_down;Xie et. al (2022);;4629;
EPS8L1;Melanoma_down;Xie et. al (2022);;54869;
ACKR1;Melanoma_down;Xie et. al (2022);;2532;
CCL18;Melanoma_down;Xie et. al (2022);;6362;
SULT2B1;Melanoma_down;Xie et. al (2022);;6820;
FABP5;Melanoma_down;Xie et. al (2022);;2171;
CLDN4;Melanoma_down;Xie et. al (2022);;1364;
LTB4R;Melanoma_down;Xie et. al (2022);;1241;
APBA2;Melanoma_down;Xie et. al (2022);;321;
COL8A2;Melanoma_down;Xie et. al (2022);;1296;
CD1E;Melanoma_down;Xie et. al (2022);;913;
ABCA12;Melanoma_down;Xie et. al (2022);;26154;
DPT;Melanoma_down;Xie et. al (2022);;1805;
SDC1;Melanoma_down;Xie et. al (2022);;6382;
NOD2;Melanoma_down;Xie et. al (2022);;64127;
HCAR3;Melanoma_down;Xie et. al (2022);;8843;
SPRR2C;Melanoma_down;Xie et. al (2022);;6702;
CDKN1C;Melanoma_down;Xie et. al (2022);;1028;
SSH3;Melanoma_down;Xie et. al (2022);;54961;
CTSG;Melanoma_down;Xie et. al (2022);;1511;
FBLN2;Melanoma_down;Xie et. al (2022);;2199;
HPGD;Melanoma_down;Xie et. al (2022);;3248;
CA12;Melanoma_down;Xie et. al (2022);;771;
PALMD;Melanoma_down;Xie et. al (2022);;54873;
NSG1;Melanoma_down;Xie et. al (2022);;27065;
SERPINB13;Melanoma_down;Xie et. al (2022);;5275;
SPTBN2;Melanoma_down;Xie et. al (2022);;6712;
KLK6;Melanoma_down;Xie et. al (2022);;5653;
STMN2;Melanoma_down;Xie et. al (2022);;11075;
IMPA2;Melanoma_down;Xie et. al (2022);;3613;
OTUB2;Melanoma_down;Xie et. al (2022);;78990;
TPSAB1;Melanoma_down;Xie et. al (2022);;7177;
GNA15;Melanoma_down;Xie et. al (2022);;2769;
BDKRB2;Melanoma_down;Xie et. al (2022);;624;
LAMB3;Melanoma_down;Xie et. al (2022);;3914;
GPX3;Melanoma_down;Xie et. al (2022);;2878;
ALDH3B2;Melanoma_down;Xie et. al (2022);;222;
MMP28;Melanoma_down;Xie et. al (2022);;79148;
SCUBE2;Melanoma_down;Xie et. al (2022);;57758;
GAS6;Melanoma_down;Xie et. al (2022);;2621;
PRSS3;Melanoma_down;Xie et. al (2022);;5646;
CDCP1;Melanoma_down;Xie et. al (2022);;64866;
C1orf106;Melanoma_down;Xie et. al (2022);;55765;
PTPRF;Melanoma_down;Xie et. al (2022);;5792;
HPGD;Melanoma_down;Xie et. al (2022);;3248;
C1orf68;Melanoma_down;Xie et. al (2022);;100129271;
PRSS2;Melanoma_down;Xie et. al (2022);;5645;
PITX1;Melanoma_down;Xie et. al (2022);;5307;
FERMT1;Melanoma_down;Xie et. al (2022);;55612;
DKK3;Melanoma_down;Xie et. al (2022);;27122;
SCGB2A2;Melanoma_down;Xie et. al (2022);;4250;
GATA3;Melanoma_down;Xie et. al (2022);;2625;
CLTB;Melanoma_down;Xie et. al (2022);;1212;
IRF6;Melanoma_down;Xie et. al (2022);;3664;
CHIT1;Melanoma_down;Xie et. al (2022);;1118;
GPX2;Melanoma_down;Xie et. al (2022);;2877;
CA2;Melanoma_down;Xie et. al (2022);;760;
NTRK2;Melanoma_down;Xie et. al (2022);;4915;
KRT13;Melanoma_down;Xie et. al (2022);;3860;
LAMC3;Melanoma_down;Xie et. al (2022);;10319;
CCL22;Melanoma_down;Xie et. al (2022);;6367;
LINC00302;Melanoma_down;Xie et. al (2022);;388699;
HLF;Melanoma_down;Xie et. al (2022);;3131;
PTPRF;Melanoma_down;Xie et. al (2022);;5792;
CLTB;Melanoma_down;Xie et. al (2022);;1212;
SERPINB13;Melanoma_down;Xie et. al (2022);;5275;
MAST4;Melanoma_down;Xie et. al (2022);;375449;
ABLIM1;Melanoma_down;Xie et. al (2022);;3983;
UNC93A;Melanoma_down;Xie et. al (2022);;54346;
DIO2;Melanoma_down;Xie et. al (2022);;1734;
CBLC;Melanoma_down;Xie et. al (2022);;23624;
DKK3;Melanoma_down;Xie et. al (2022);;27122;
ALDH2;Melanoma_down;Xie et. al (2022);;217;
SOX9;Melanoma_down;Xie et. al (2022);;6662;
SERPINB2;Melanoma_down;Xie et. al (2022);;5055;
STXBP6;Melanoma_down;Xie et. al (2022);;29091;
PRRX2;Melanoma_down;Xie et. al (2022);;51450;
EDN1;Melanoma_down;Xie et. al (2022);;1906;
SCGB1D2;Melanoma_down;Xie et. al (2022);;10647;
EPS8L2;Melanoma_down;Xie et. al (2022);;64787;
NEBL;Melanoma_down;Xie et. al (2022);;10529;
WNT5A;Melanoma_down;Xie et. al (2022);;7474;
CDKN1C;Melanoma_down;Xie et. al (2022);;1028;
GPRC5C;Melanoma_down;Xie et. al (2022);;55890;
PLEK2;Melanoma_down;Xie et. al (2022);;26499;
ELOVL4;Melanoma_down;Xie et. al (2022);;6785;
ITGBL1;Melanoma_down;Xie et. al (2022);;9358;
MUC1;Melanoma_down;Xie et. al (2022);;4582;
LAMC2;Melanoma_down;Xie et. al (2022);;3918;
FZD10;Melanoma_down;Xie et. al (2022);;11211;
MYH11;Melanoma_down;Xie et. al (2022);;4629;
PTN;Melanoma_down;Xie et. al (2022);;5764;
PLA2G3;Melanoma_down;Xie et. al (2022);;50487;
LTBP1;Melanoma_down;Xie et. al (2022);;4052;
F3;Melanoma_down;Xie et. al (2022);;2152;
DIO2;Melanoma_down;Xie et. al (2022);;1734;
DOK4;Melanoma_down;Xie et. al (2022);;55715;
GATA3;Melanoma_down;Xie et. al (2022);;2625;
ACAP1;Melanoma_down;Xie et. al (2022);;9744;
CIDEA;Melanoma_down;Xie et. al (2022);;1149;
CYP4F12;Melanoma_down;Xie et. al (2022);;66002;
TNXB;Melanoma_down;Xie et. al (2022);;7148;
PTPRF;Melanoma_down;Xie et. al (2022);;5792;
CCL21;Melanoma_down;Xie et. al (2022);;6366;
FHOD3;Melanoma_down;Xie et. al (2022);;80206;
MAL;Melanoma_down;Xie et. al (2022);;4118;
COL7A1;Melanoma_down;Xie et. al (2022);;1294;
HYAL1;Melanoma_down;Xie et. al (2022);;3373;
SMPD3;Melanoma_down;Xie et. al (2022);;55512;
CXCR2;Melanoma_down;Xie et. al (2022);;3579;
KRT6B;Melanoma_down;Xie et. al (2022);;3854;
COL6A2;Melanoma_down;Xie et. al (2022);;1292;
